Related references
Note: Only part of the references are listed.Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Treatment Selection in Depression
Zachary D. Cohen et al.
Annual Review of Clinical Psychology (2018)
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Andrea Cipriani et al.
LANCET (2018)
Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression A Randomized Clinical Trial
Diego A. Pizzagalli et al.
JAMA PSYCHIATRY (2018)
Prevalence and patterns of antidepressant switching amongst primary care patients in the UK
Becky Mars et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Morbidity in Depressive Disorders
Ross J. Baldessarini et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
What big data can do for treatment in psychiatry
Claire M. Gillan et al.
CURRENT OPINION IN BEHAVIORAL SCIENCES (2017)
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
Janus Christian Jakobsen et al.
BMC PSYCHIATRY (2017)
Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study
Christian A. Webb et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The efficacy and acceptability of psychological interventions for depression: where we are now and where we are going
Steven. D. Hollon
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2016)
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design
Madhukar H. Trivedi et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Depression sum-scores don't add up: why analyzing specific depression symptoms is essential
Eiko I. Fried et al.
BMC MEDICINE (2015)
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences
Joanna Moncrieff et al.
CONTEMPORARY CLINICAL TRIALS (2015)
Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study
Eiko I. Fried et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
Atul R. Mahableshwarkar et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Clinical trial methodology and drug-placebo differences
Irving Kirsch
WORLD PSYCHIATRY (2015)
A Cognitive-Emotional Biomarker for Predicting Remission with Antidepressant Medications: A Report from the iSPOT-D Trial
Amit Etkin et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Predicting Optimal Outcomes in Cognitive Therapy or Interpersonal Psychotherapy for Depressed Individuals Using the Personalized Advantage Index Approach
Marcus J. H. Huibers et al.
PLOS ONE (2015)
Cognitive Dysfunction in Major Depressive Disorder: Effects on Psychosocial Functioning and Implications for Treatment
Raymond W. Lam et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2014)
Prognostic Subgroups for Citalopram Response in the STAR*D Trial
Ewgeni Jakubovski et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration
Robert J. DeRubeis et al.
PLOS ONE (2014)
What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment
Susan Ball et al.
ANNALS OF GENERAL PSYCHIATRY (2014)
A review of selected candidate endophenotypes for depression
Brandon L. Goldstein et al.
CLINICAL PSYCHOLOGY REVIEW (2014)
Reduced Reward Learning Predicts Outcome in Major Depressive Disorder
Elske Vrieze et al.
BIOLOGICAL PSYCHIATRY (2013)
Random forest methodology for model-based recursive partitioning: the mobForest package for R
Nikhil R. Garge et al.
BMC BIOINFORMATICS (2013)
Prevalence of treatment-resistant depression in primary care: cross-sectional data
Laura Thomas et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2013)
Side effects of antidepressants during long-term use in a naturalistic setting
Pierre M. Bet et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach
Helena Chmura Kraemer
STATISTICS IN MEDICINE (2013)
When does depression become a disorder? Using recurrence rates to evaluate the validity of proposed changes in major depression diagnostic thresholds
Jerome C. Wakefield et al.
WORLD PSYCHIATRY (2013)
Comparison of imputation methods for missing laboratory data in medicine
Akbar K. Waljee et al.
BMJ OPEN (2013)
Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
Callie L. McGrath et al.
JAMA PSYCHIATRY (2013)
Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy
Jay C. Fournier et al.
BEHAVIOUR RESEARCH AND THERAPY (2013)
MissForest-non-parametric missing value imputation for mixed-type data
Daniel J. Stekhoven et al.
BIOINFORMATICS (2012)
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
Stefan Leucht et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Antidepressant Effects on Emotional Temperament: Toward a Biobehavioral Research Paradigm for Major Depressive Disorder
David P. Soskin et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study
D. Saragoussi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Anhedonia Predicts Poorer Recovery Among Youth With Selective Serotonin Reuptake Inhibitor Treatment-Resistant Depression
Dana L. McMakin et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2012)
Biomarkers predicting treatment outcome in depression: what is clinically significant?
Rudolf Uher et al.
PHARMACOGENOMICS (2012)
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms
R. Uher et al.
PSYCHOLOGICAL MEDICINE (2012)
Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications
Ni A. Khin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Voodoo Correlations Are Everywhere-Not Only in Neuroscience
Klaus Fiedler
PERSPECTIVES ON PSYCHOLOGICAL SCIENCE (2011)
Antidepressant Monotherapy: A Claims Database Analysis of Treatment Changes and Treatment Duration
Dominique Milea et al.
CLINICAL THERAPEUTICS (2010)
Antidepressant Drug Effects and Depression Severity A Patient-Level Meta-analysis
Jay C. Fournier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Serotonin Transporter Genotype and Action Monitoring Dysfunction: A Possible Substrate Underlying Increased Vulnerability to Depression
Avram J. Holmes et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Personality Change During Depression Treatment A Placebo-Controlled Trial
Tony Z. Tang et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder
Ixchel Herrera-Guzman et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Costs Associated With Changes in Antidepressant Treatment in a Managed Care Population With Major Depressive Disorder
Jennifer Schultz et al.
PSYCHIATRIC SERVICES (2009)
Antidepressant Switching Among Adherent Patients Treated for Depression
Steven C. Marcus et al.
PSYCHIATRIC SERVICES (2009)
Course and outcome of depressive disorders in primary care: a prospective 18-month study
M. S. Vuorilehto et al.
PSYCHOLOGICAL MEDICINE (2009)
Prediction of Response to Medication and Cognitive Therapy in the Treatment of Moderate to Severe Depression
Jay C. Fournier et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2009)
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
Maurizio Fava et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task
Diego A. Pizzagalli et al.
BIOLOGICAL PSYCHIATRY (2008)
Personality and differential treatment response in major depression: A randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy
R. Michael Bagby et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2008)
Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder
Lena C. Quilty et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
Selective publication of antidepressant trials and its influence on apparent efficacy
Erick H. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Single dose of a dopamine agonist impairs reinforcement learning in humans: Behavioral evidence from a laboratory-based measure of reward responsiveness
Diego A. Pizzagalli et al.
PSYCHOPHARMACOLOGY (2008)
Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
Daniel Souery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Toward an objective characterization of an anhedonic phenotype: A signal detection approach
DA Pizzagalli et al.
BIOLOGICAL PSYCHIATRY (2005)
Bootstrap methods for developing predictive models
PC Austin et al.
AMERICAN STATISTICIAN (2004)
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2003)
The endophenotype concept in psychiatry: Etymology and strategic intentions
II Gottesman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Severity of depression and response to antidepressants and placebo: An analysis of the Food and Drug Administration database
A Khan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Share Paper
